Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2018
Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross-Sectional StudyAlain Lescoat, Cécile Marie Yelnik, Guillaume Coiffier, et al.
Cardiovascular Diabetology|October 19, 2022
The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)Gemma Llauradó, Bogdan Vlacho, Matthieu Wargny, et al.
Diabetes & Metabolism|March 18, 2025
Persistent gaps in the implementation of lipid-lowering therapy in patients with established atherosclerotic cardiovascular disease: A French nationwide studyMatthieu Wargny, Thomas Goronflot, Pierre-Guillaume Piriou, et al.
Journal of Clinical Medicine|November 25, 2020
Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with Diabetes and COVID-19: The DIABCOVID StudyAdèle Lasbleiz, Bertrand Cariou, Patrice Darmon, et al.
Metabolism: Clinical and Experimental|December 1, 2019
Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetesOscar Chávez-Talavera, Matthieu Wargny, Matthieu Pichelin, et al.
The Journal of Experimental Medicine|July 9, 2020
Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetesIoanna Mosialou, Steven Shikhel, Na Luo, et al.
Atherosclerosis|September 28, 2018
Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk populationMatthieu Wargny, Pierre-Henri Ducluzeau, Jean-Michel Petit, et al.
Journal of the American Geriatrics Society|March 25, 2023
Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes: The HYPOAGE observational studyAnne-Sophie Boureau, Béatrice Guyomarch, Pierre Gourdy, et al.
Clinical Chemistry|April 7, 2025
Methylglyoxal-Induced Glycation of Plasma Albumin: From Biomarker Discovery to Clinical Use for Prediction of New-Onset Diabetes in Individuals with PrediabetesArsênio Rodrigues Oliveira, Chloé Chevalier, Matthieu Wargny, et al.
Diabetes & Metabolism|September 29, 2022
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort studyJulie Pires Da Silva, Matthieu Wargny, Jérémy Raffin, et al.
Pageof 7